Fairfield Market Research Pharmaceutical Elixir Market Size to Reach US$13 Bn by 2030

Pharmaceutical Elixir Market

Global Pharmaceutical Elixir Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Type Coverage, By Distribution Channel Coverage, By End User Coverage, By Geographic Coverage and Leading Companies)

Published Date: Oct 2023 | Format: | No. of Pages: 190

Industry: Pharmaceuticals & Biotechnology | Author Name: Sayali

Request Customisation / Information

  

FAQ : Pharmaceutical Elixir Market

The global pharmaceutical elixir market size is approximately US$7.1 Bn as of 2022.

The global market for pharmaceutical elixir has been projected to exhibit a value CAGR of 9% between the forecast years, 2023 and 2030.

Currently, North America is the largest pharmaceutical elixir market in the world. Some of the largest industry players include Merck & Co, Sanofi SA, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Bristol-Myers Squibb Company, Roche Holding AG, and Eli Lilly and Company.

The primary growth driving factors projected to drive the expansion of the pharmaceutical elixir market is the consistently growing expenditure in the healthcare industry, and dramatically rising prevalence of chronic diseases.

The non-medical elixir type segment presently leads the market for pharmaceutical elixirs, whereas hospital pharmacies continue to be the prime distribution channel for the market participants.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services